You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

TWYNSTA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for TWYNSTA
Drug patent expirations by year for TWYNSTA
Drug Prices for TWYNSTA

See drug prices for TWYNSTA

Recent Clinical Trials for TWYNSTA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hanlim Pharm. Co., Ltd.Phase 1
Addpharma Inc.Phase 3
Research Institute for Complex Problems of Cardiovascular Diseases, RussiaPhase 4

See all TWYNSTA clinical trials

US Patents and Regulatory Information for TWYNSTA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim TWYNSTA amlodipine besylate; telmisartan TABLET;ORAL 022401-001 Oct 16, 2009 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Boehringer Ingelheim TWYNSTA amlodipine besylate; telmisartan TABLET;ORAL 022401-004 Oct 16, 2009 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Boehringer Ingelheim TWYNSTA amlodipine besylate; telmisartan TABLET;ORAL 022401-003 Oct 16, 2009 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Boehringer Ingelheim TWYNSTA amlodipine besylate; telmisartan TABLET;ORAL 022401-002 Oct 16, 2009 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TWYNSTA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim TWYNSTA amlodipine besylate; telmisartan TABLET;ORAL 022401-001 Oct 16, 2009 ⤷  Try a Trial ⤷  Try a Trial
Boehringer Ingelheim TWYNSTA amlodipine besylate; telmisartan TABLET;ORAL 022401-003 Oct 16, 2009 ⤷  Try a Trial ⤷  Try a Trial
Boehringer Ingelheim TWYNSTA amlodipine besylate; telmisartan TABLET;ORAL 022401-004 Oct 16, 2009 ⤷  Try a Trial ⤷  Try a Trial
Boehringer Ingelheim TWYNSTA amlodipine besylate; telmisartan TABLET;ORAL 022401-002 Oct 16, 2009 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for TWYNSTA

See the table below for patents covering TWYNSTA around the world.

Country Patent Number Title Estimated Expiration
Germany 4212250 ⤷  Try a Trial
China 1050122 ⤷  Try a Trial
Japan H05279341 ⤷  Try a Trial
Singapore 43083 Benzinidaziles pharmaceutical compositions containing these compounds and processes for preparing them ⤷  Try a Trial
Norway 2011005 ⤷  Try a Trial
Russian Federation 2053229 ПРОИЗВОДНЫЕ БЕНЗИМИДАЗОЛА И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ВОТНОШЕНИИ АНГИОТЕНЗИНА, НА ИХ ОСНОВЕ (BENZIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION SHOWING ANTAGONISTIC ACTIVITY WITH RELATION TO ANGIOTENSIN BASED ON THEREOF) ⤷  Try a Trial
Bulgaria 62309 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for TWYNSTA

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0502314 C00502314/03 Switzerland ⤷  Try a Trial PRODUCT NAME: TELMISARTAN + AMLODIPIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 61270 08.11.2010
0503785 C300486 Netherlands ⤷  Try a Trial PRODUCT NAME: COMBINATIE VAN OLMESARTANMEDOXOMIL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, AMLODIPINEBESYLAAT AND HYDROCHLOORTHIAZIDE; NATL REGISTRATION NO/DATE: RVG 106667, RVG 106671-74, RVG 106682-86 20101221; FIRST REGISTRATION: DE 79810.00.00-79814.00.00 20101216
1507558 2012/018 Ireland ⤷  Try a Trial PRODUCT NAME: ALISKIREN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AMLODIPINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND HYDROCHLOROTHIAZIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.; NAT REGISTRATION NO/DATE: EU/1/11/730/001-060 20111122; FIRST REGISTRATION NO/DATE: SWITZERLAND 6167801-6167805 20110705
0502314 C300095 Netherlands ⤷  Try a Trial PRODCUT NAME: TELMISARTAN, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH VERDRAAGBAAR ZOUT, EN HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/02/213/001-010 20020419
0502314 91802 Luxembourg ⤷  Try a Trial 91802, EXPIRES: 20170131
1003503 05C0048 France ⤷  Try a Trial PRODUCT NAME: AMLODIPINE OU UN DE SES SELS D?ADDITION D?ACIDES PHARMACAUTIQUEMENT ACCEPTABLES/ ATORVASTATINE OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: NL 29929 DU 20050707; REGISTRATION NO/DATE AT EEC: NL 29929 DU 20050707
0443983 C300445 Netherlands ⤷  Try a Trial PRODUCT NAME: VALSARTAN, AMLODIPINE EN HYDROCHLOORTHIAZIDE EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/09/569/001-060 20091016
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.